Go to the list of all blogs
Arthur Evans's Avatar
published in Blogs
Jun 04, 2026
Why Is Broadcom (AVGO) Stock Down -15% Today?

Why Is Broadcom (AVGO) Stock Down -15% Today?

Key Takeaways

  • Broadcom (AVGO) shares are down approximately 15% on June 4, 2026, after closing at $479.23 on June 3, with shares trading as low as $405.51 intraday
  • The primary catalyst is investor disappointment following Broadcom's Q2 fiscal 2026 earnings release: Q3 AI chip revenue guidance of $16 billion fell short of analyst expectations of $17.2 billion
  • CEO Hock Tan declined to raise the company's widely-anticipated annual AI semiconductor revenue target, reaffirming but not upgrading the $100 billion benchmark for fiscal 2027
  • Enterprise software revenue came in below StreetAccount estimates, adding a secondary layer of disappointment
  • The stock had rallied nearly 40% year-to-date and hit multiple all-time highs in the days leading up to earnings, creating an exceptionally high bar
  • Traders are now watching whether the sell-off stabilizes around key technical support and whether analysts revise price targets in the coming sessions

Opening Summary

Broadcom Inc. (AVGO) is a global semiconductor and infrastructure software powerhouse, best known for designing custom AI accelerator chips (XPUs and ASICs) for hyperscale cloud operators, as well as networking silicon and enterprise software — including the VMware platform it acquired in 2023. On Wednesday, June 3, 2026, AVGO closed at $479.23. In Thursday's trading session on June 4, shares dropped approximately 15%, falling as low as $405.51, as investors reacted sharply to an earnings report that, while technically ahead on EPS, missed the sky-high expectations the market had built in during a multi-week pre-earnings rally.  The sell-off reflects not a failed quarter, but a forward guidance picture that simply did not match what bulls had priced in.

Earnings Beat, But Guidance Disappointed

Broadcom reported Q2 fiscal 2026 adjusted EPS of $2.44, ahead of the consensus estimate of $2.39–$2.40.  Revenue came in at $22.19 billion, a 48% jump year-over-year, though this narrowly missed some analysts' estimates of $22.27 billion.  On the surface, the company also raised its Q3 revenue guidance to $29.4 billion, topping Wall Street's $28.53–$28.61 billion consensus.

However, the detail that rattled markets most was AI chip revenue guidance for the upcoming quarter: Broadcom projected $16 billion in Q3 AI semiconductor revenue, below analyst expectations of $17.2 billion.  For a stock that had been riding AI optimism to record highs, even a small miss on the forward AI number proved more than enough to trigger aggressive selling. Net income did surge 88% year-over-year to $9.31 billion, but the market's focus remained squarely on AI trajectory.

The $100 Billion AI Target Left Untouched

The most consequential moment of the earnings call may have been what CEO Hock Tan did not say.  Investors had broadly expected Tan to raise Broadcom's $100 billion annual AI semiconductor revenue target for fiscal 2027, given that Q2 AI revenue had already surged 143% year-over-year to $10.8 billion and AI bookings exceeded $30 billion.  Instead, Tan simply reaffirmed the existing target: "We expect this momentum to persist into fiscal year 2027 and reaffirm our guidance for AI semiconductor revenue to exceed $100 billion."

In a market environment where AI growth stories are expected to continuously upgrade their outlooks, a reaffirmation read as a ceiling rather than a floor.  "The expectations were quite elevated going into this report, and I think the reaction you're observing in the shares reflects that," said Angelo Zino, senior vice president at CFRA Research.

Software Segment Miss Amplifies the Selloff

Beyond semiconductors, Broadcom's enterprise software division — anchored by VMware — reported revenue that came in below StreetAccount analyst estimates.  While the segment continued to grow, the shortfall added a second front of disappointment. Investors have been watching the VMware integration closely as a key pillar of Broadcom's non-chip revenue diversification strategy, and any stumble in that segment tends to raise questions about the longer-term earnings mix.

High Expectations Built Into a Record-High Stock

Context matters here. AVGO shares had climbed nearly 40% year-to-date through Wednesday's close, outpacing the Nasdaq's 16% gain over the same period.  In the five trading sessions before earnings, the stock hit several all-time highs as investors aggressively positioned for what they anticipated would be a blowout report with upward AI guidance revisions.  That positioning created a classic "buy the rumor, sell the news" setup, where even a credible beat-and-raise quarter could not satisfy the premium valuation the stock had accumulated.

Market Context and Trading Activity

Volume on June 4 surged dramatically, with AVGO trading as low as $405.51 — a level not seen in recent weeks — before recovering slightly toward $422.  The prior session on June 3 had already drawn over 50 million shares in volume, more than double the average, as traders positioned ahead of the report.  Semiconductor-focused ETFs including SMH and SOXX faced sympathy pressure given Broadcom's substantial index weighting. Despite the selloff, analyst sentiment remained broadly constructive — Deutsche Bank, for instance, actually raised its price target on AVGO to $515 on June 4, maintaining a Buy rating.  From a technical standpoint, the break below the $420–$430 range threatens key support levels that had underpinned the stock's multi-month rally.

Trending AI Robots

For traders navigating volatile, earnings-driven sessions like today's, Tickeron's Trending AI Robots page offers a curated selection of the platform's top-performing AI trading bots under current market conditions. Tickeron operates hundreds of AI bots covering thousands of tickers, spanning diverse strategies, timeframes, risk profiles, and performance metrics — but only the strongest performers in the live market environment earn a place in this featured section. Whether a trader is looking for momentum strategies, mean-reversion approaches, or sector-specific setups, the bots vary widely in trade frequency, drawdown tolerance, and the symbols they cover. Traders looking for data-driven, systematic approaches to volatile markets like today's are encouraged to explore what the Trending AI Robots section currently has to offer.

What Comes Next for AVGO

The next major scheduled catalyst for AVGO is its fiscal Q3 2026 earnings report, expected around early September 2026, where investors will scrutinize whether AI semiconductor revenue is tracking toward or above the $16 billion quarterly guidance.  Any upward revision to the $100 billion annual AI target — or a new, higher multi-year benchmark — would likely be the most powerful re-rating catalyst for the stock. Hyperscaler capital expenditure updates from Google, Meta, Microsoft, and Amazon will also be closely tracked, as Broadcom's custom ASIC business is directly dependent on their AI infrastructure investment cycles.

On the software side, continued VMware enterprise retention metrics and contract renewal rates will be watched carefully. With 43 buy ratings and only 1 hold among covering analysts as of the most recent data, Wall Street's long-term conviction in AVGO remains largely intact — but near-term sentiment has clearly shifted following the earnings-driven move, and valuation multiples will need time to reset.  Key risks include semiconductor export restrictions, a potential pullback in hyperscaler AI spending, and broader macro uncertainty.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitation

Related Ticker: AVGO

Contributor

Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.


AVGO's MACD Histogram just turned positive

The Moving Average Convergence Divergence (MACD) for AVGO turned positive on September 21, 2026. Looking at past instances where AVGO's MACD turned positive, the stock continued to rise in 47 of 55 cases over the following month. The odds of a continued upward trend are 85%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where AVGO's RSI Indicator exited the oversold zone, 9 of 12 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 75%.

The Momentum Indicator moved above the 0 level on September 28, 2026. You may want to consider a long position or call options on AVGO as a result. In 70 of 85 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 82%.

Following a +2.12% 3-day Advance, the price is estimated to grow further. Considering data from situations where AVGO advanced for three days, in 274 of 345 cases, the price rose further within the following month. The odds of a continued upward trend are 79%.

AVGO may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 48 of 71 cases where AVGO's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 68%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where AVGO declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 60%.

The Aroon Indicator for AVGO entered a downward trend on September 25, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is 15 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 73, placing this stock better than average.

The Tickeron SMR rating for this company is 23 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is 49 (best 1 - 100 worst), indicating fairly steady price growth. AVGO’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of 71 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: AVGO's P/B Ratio (16.750) is slightly higher than the industry average of (7.811). P/E Ratio (44.588) is within average values for comparable stocks, (160.549). Projected Growth (PEG Ratio) (0.346) is also within normal values, averaging (3.705). Dividend Yield (0.007) settles around the average of (0.006) among similar stocks. P/S Ratio (18.622) is also within normal values, averaging (44.558).

The Tickeron PE Growth Rating for this company is 89 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

Notable companies

The most notable companies in this group are NVIDIA Corp (NASDAQ:NVDA), Taiwan Semiconductor Manufacturing Company Ltd (NYSE:TSM), Broadcom Inc. (NASDAQ:AVGO), Micron Technology (NASDAQ:MU), Advanced Micro Devices (NASDAQ:AMD), Intel Corp (NASDAQ:INTC), Texas Instruments (NASDAQ:TXN), Marvell Technology (NASDAQ:MRVL), QUALCOMM (NASDAQ:QCOM), Analog Devices (NASDAQ:ADI).

Industry description

The semiconductor industry manufacturers all chip-related products, including research and development. These chips are used in innumerable electronic devices, including computers, cell phones, smartphones, and GPSs. Intel Corporation, NVIDIA Corp., and Broadcomm are some of the prominent players in this industry. Semiconductor companies usually tend to do well during periods of healthy economic growth, thereby inducing further research and development in the industry – which in turn augurs well for productivity and growth in the economy. In the near future, demand for semiconductor products (and possibly innovation within the segment) should only expand further, with the proliferation of 5G, autonomous vehicles, IoT, and various AI-driven electronics set to herald a new, advanced chapter in the technology-driven world as we know it. With burgeoning prospects comes great competition. In 2015, SIA estimated that U.S. semiconductor industry ranks as the second most competitive U.S. industry out of 2882 U.S. industries designated manufacturers by the U.S. Census Bureau.

Market Cap

The average market capitalization across the Semiconductors Industry is 213.1B. The market cap for tickers in the group ranges from 86.8K to 5.53T. NVDA holds the highest valuation in this group at 5.53T. The lowest valued company is STRB at 86.8K.

High and low price notable news

The average weekly price growth across all stocks in the Semiconductors Industry was 2%. For the same Industry, the average monthly price growth was 12%, and the average quarterly price growth was 56%. MX experienced the highest price growth at 17%, while CBRS experienced the biggest fall at -13%.

Volume

The average weekly volume growth across all stocks in the Semiconductors Industry was 10%. For the same stocks of the Industry, the average monthly volume growth was -1% and the average quarterly volume growth was -49%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 61
P/E Growth Rating: 51
Price Growth Rating: 44
SMR Rating: 72
Profit Risk Rating: 72
Seasonality Score: 18 (-100 ... +100)
View a ticker or compare two or three
AVGO
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a manufacturer of digital and analog semiconductor products

Industry Semiconductors

Industry
Semiconductors
Address
3421 Hillview Avenue
Phone
+1 650 427-6000
Employees
33000
Web
https://www.broadcom.com
Interact to see
Advertisement
MRSH stock declined approximately -9% over the past 30 days, driven by sector-wide AI disruption fears and analyst downgrades. Over the past quarter, the stock fell around -7%, amid softening insurance rates and declining fiduciary interest income.
MCO stock declined approximately -9% over the last 30 days amid profit-taking, insider selling, and sector-wide concerns in financial data analytics. Over the past quarter, shares fell around -18%, reflecting a correction from January highs despite strong Q4 2025 earnings. Key drivers include post-earnings selloff after Q4 results, analyst price target cuts, and broader market volatility in credit ratings sector.
SNOW stock declined approximately -9% over the last 30 days, from around $168 to $153, amid post-earnings profit-taking and analyst caution despite strong results. Over the past quarter, the stock fell about -31%, from near $223, reflecting broader sector pressures and valuation concerns in cloud software.
WDS stock surged +24% over the past 30 days, driven by a sharp rally in oil and LNG prices amid Middle East supply disruptions, including Strait of Hormuz issues and strikes on Qatar's Ras Laffan facility. Over the past quarter, the stock climbed +55%, reflecting sustained energy market volatility and Woodside's strong production from assets like Sangomar and Pluto LNG.
HMC stock declined -19% over the past 30 days amid major setbacks in EV strategy, including cancellation of North American EV models and up to $15.7 billion in related losses. Over the past quarter, shares fell -18%, driven by persistent auto segment weakness, tariff impacts, and revised FY2026 forecasts to a net loss. Key catalysts include March EV reassessment announcement causing a 5%+ drop, Q3 earnings beat overshadowed by one-time charges and guidance concerns, and Sony-Honda JV EV project halt.
EL stock plunged approximately -39% over the past 30 days amid merger discussions with Puig, tariff pressures, and restructuring costs, marking a highly volatile period. Over the past quarter, the stock is down around -37%, reflecting broader sector headwinds despite earlier quarterly earnings beats. Key drivers include confirmation of potential business combination with Puig sparking uncertainty, ongoing $100 million tariff impacts, and elevated restructuring expenses.
ESLT stock rose +13% over the past 30 days, driven primarily by a blowout Q4 2025 earnings report with revenue up 11% and EPS beating estimates by over 10%. Over the past quarter, shares surged +52%, fueled by a record $28.1 billion order backlog, up significantly year-over-year, amid heightened global defense demand. Geopolitical tensions in the Middle East boosted demand for Elbit's systems, alongside major contract wins totaling hundreds of millions from international clients.
EQT stock rose approximately +10% over the last 30 days, driven by strong Q4 2025 earnings beat, robust free cash flow guidance for 2026, and analyst price target increases. Over the past quarter, shares gained around +23%, fueled by operational efficiencies, natural gas price recovery, and positive sector sentiment amid LNG demand growth.
Robin Energy Ltd is a Cyprus-based shipping company focused on ocean and deep-sea freight transportation. As a holding entity, it acquires, owns, charters, and manages oceangoing tanker vessels worldwide. The core of its business lies in energy transportation services, mainly through handysize tankers and LPG carriers. In the competitive marine shipping industry, RBNE positions itself as a growth-oriented player, expanding its fleet and locking in multi-year charters. Recent developments, such as vessel acquisitions and Bitcoin treasury allocations, leave it exposed to shipping cycles and alternative asset volatility. From what I see, this mix contributes to the erratic stock price behavior we've observed amid shifting global energy demand and freight rates.
NG stock plunged -42% over the past 30 days amid sharp declines from mid-March peaks around $14, driven by profit-taking after a multi-year rally and sector-wide weakness in gold mining stocks. Over the past quarter, the stock is down -14%, reflecting volatility from early-year gains tied to financing successes offset by recent macro pressures and permitting concerns. Key drivers include gold price fluctuations due to interest rate expectations, profit-taking post-240%+ annual surge, and no immediate production revenue despite Donlin Gold project advancements.
CRBU stock declined approximately -10% over the past 30 days, reflecting volatility amid clinical updates and financing concerns. Over the past quarter, the stock rose about +12%, driven by positive earnings beats and pipeline progress. Key drivers include Q4 2025 earnings beat, vispa-cel Phase 3 plans, but offset by cash burn and need for additional capital.
Shares of Viridian Therapeutics (VRDN) are down approximately 32% in premarket trading on March 30, 2026, against a prior closing price of $27.39 on March 27, 2026, implying a premarket price near $18.63. The primary catalyst is the release of topline Phase 3 REVEAL-1 clinical trial data for elegrobart (VRDN-003) in patients with active thyroid eye disease (TED), long anticipated as the company's most critical near-term de-risking event.
SYY shares are trading approximately -6.40% lower in premarket trading on March 30, 2026, from a prior close of $81.80 to roughly $76.56. The primary catalyst is Sysco's announcement of a $29.1 billion definitive agreement to acquire Jetro Restaurant Depot, one of the nation's largest Cash & Carry food wholesalers.
Northwest Biotherapeutics, Inc. (NWBO) is a clinical-stage biotechnology company focused on developing personalized immune therapies, primarily dendritic cell-based vaccines under its DCVax platform. The company's lead candidate, DCVax-L, targets glioblastoma multiforme (GBM), a lethal brain cancer, following completion of a Phase III trial. DCVax-Direct addresses inoperable solid tumors, with Phase I/II data available. NWBO operates in the competitive immunotherapy sector against players like large-cap biotechs, relying on a proprietary manufacturing process for cost-effective production.
FingerMotion, Inc. (FNGR) operates as a mobile data specialist, delivering mobile payment and recharge platform solutions mainly in China. The company's core revolves around telecommunication products and services, such as top-up recharges, data plans, SMS and MMS services, big data insights for consumer behavior analysis, and rich communication services (RCS) platforms. It also provides value-added products through partnerships with telecom providers and e-commerce platforms.
NIO Inc. (NIO) stands out as a leading Chinese electric vehicle manufacturer focused on premium smart EVs. The company designs, develops, and sells high-end battery electric vehicles, bolstered by its Battery-as-a-Service model that lets customers swap batteries at stations rather than owning them. In the cutthroat Chinese EV space, NIO competes directly with firms like XPEV and LI.
Xcel Energy Inc. (XEL) stands out as a major U.S. electric and natural gas utility, serving about 3.7 million electric and 2.2 million natural gas customers across eight states, mainly in the Midwest and West. The company focuses on regulated utilities, handling electricity generation, transmission, and distribution, while increasingly prioritizing renewable sources like wind and solar. Its model centers on steady, regulated returns from infrastructure investments, backed by rate cases and recovery mechanisms.
Occidental Petroleum Corporation (OXY) stands out as a leading independent energy producer, with a primary focus on hydrocarbon exploration and production. The company has significant operations in the Permian Basin, one of the U.S.'s most productive oil regions, along with assets in the Rockies, Latin America, and the Middle East. Its business model emphasizes efficient drilling, low-cost production, and carbon capture initiatives aimed at long-term sustainability.
The ProShares UltraShort Bloomberg Natural Gas (KOLD) is a leveraged inverse exchange-traded fund that seeks daily investment results, before fees and expenses, corresponding to two times the inverse (-2x) of the daily performance of the Bloomberg Natural Gas Subindex. This subindex reflects the natural gas segment of the commodities market by tracking futures contracts, primarily the second-month Henry Hub natural gas futures, weighted by liquidity and production. The fund does not invest directly in physical natural gas but uses derivatives like futures contracts and swaps to achieve its objective.
Shares of United Therapeutics (UTHR) are surging approximately +17% in premarket trading on Monday, March 30, 2026, with the market not yet open. The primary catalyst is a landmark Phase 3 clinical trial announcement: the TETON-1 pivotal study of nebulized Tyvaso® (treprostinil) met its primary endpoint for treating idiopathic pulmonary fibrosis (IPF), exceeding the already impressive treatment effects seen in the previously completed TETON-2 study.